December 7, 2025

Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab – The New England Journal of Medicine

December 7, 2025

New Extramedullary Myeloma Treatment With Bispecific Antibodies Improves Survival Dramatically – Memorial Sloan Kettering Cancer Center

December 6, 2025

ASH Annual Meeting 2025 Day 1: Promising Results Across the Myeloma Spectrum

The 67th ASH Annual Meeting is underway in Orlando, where more than 30,000 experts have gathered to share the newest research in multiple myeloma and other blood cancers. The MMRF team is here on the ground, connecting with leaders in the field and bringing you updates as they happen. Over the next three days, we’ll […]

December 6, 2025

Antibody Therapy Eradicates Traces of Multiple Myeloma in Preliminary Trial – University of Miami

December 6, 2025

Antibody therapy eradicates traces of multiple myeloma in preliminary trial – Medical Xpress